This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Post Operative Nausea and Vomiting
+2

Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

Sponsored by Tanta University

About this trial

Last updated 8 months ago

Study ID

35647

Status

Active, not recruiting

Type

Interventional

Phase

Phase 3

Placebo

No

Accepting

18-75 Years
18 to 60 Years
All
All

Trial Timing

Ended 8 months ago

What is this trial about?

The aim of this study is to compare the possible efficacy of ondansetron and gabapentin on postoperative nausea and vomiting in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.

What are the participation requirements?

Yes

Inclusion Criteria

- Both male and female patients will be included.

- Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥35 kg/m2 with the presence of comorbidity such as hypertension, arthritis, and diabetes.

- Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥ 40 kg/m2 without comorbidity.

- Patients fit for anesthesia and surgery.

No

Exclusion Criteria

- Patients with BMI >55 kg/m2.

- Patients with previous procedures for the treatment of obesity.

- Pregnant females and lactating women.

- Patients with psychological or psychiatric disease

- Administration of antiemetic medication or systemic corticosteroids within 24 hours before surgery

- Patients who experienced vomiting within 24 hours before surgery.

- Patients with history of alcohol or drug abuse.

- Patients with hypersensitivity or contraindications to any of the drugs used in this study.

Locations

Location

Status